Description
Trade name:
Stopspasm
Compound:
Each tablet contains:
Phloroglucinol 62 mg.
Trimethyl Phloroglucinol 80 mg.
Auxiliary components:
Lactose monohydrate, corn starch PVP K25, microcrystalline cellulose, magnesium stearate, hydroxypropyl methylcellulose, titanium dioxide, macrogol 6000, carmosine AI.
Properties:
Treatment of spasms occurring in smooth muscle tissue. The drug has a myotropic effect on smooth muscle tissue, although its advantage over papaverine is that it has no effect on the cardiovascular system. None of the pharmacological studies have revealed cholinergic effects. Thus, no undesirable atropine-like effects were observed in patients; this is a clear advantage over other antispasmodic drugs.
Indications:
Symptomatic treatment of pain associated with functional disorders of the digestive tract and biliary tract. Treatment of spastic and painful manifestations of urinary tract diseases, such as renal colic.
Symptomatic treatment of spasmodic painful phenomena in gynecology.
Method of administration and dosage:
You can take up to 6 tablets per day.
Contraindications:
Hypersensitivity to the components of the drug.
Precautions:
Combination of phloroglucinol with major analgesics such as morphine or its derivatives should be avoided due to their spasmogenic effect.
Side effects:
Allergic reactions are possible.
Storage method:
At a temperature not exceeding 30 degrees.
